Stereotactic body radiotherapy
Stereotactic body radiotherapy is a radiation therapy with 88 clinical trials. Currently 32 active trials ongoing. Historical success rate of 76.7%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
15
Early Stage
34
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
63.9%
23 of 36 finished
36.1%
13 ended early
32
trials recruiting
88
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
Clinical Trials (88)
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
Focal Radiotherapy for Previously Treated Prostate Cancer Patients
Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease
Evaluation of Single Session Stereotactic Body Radiotherapy
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 88